<DOC>
	<DOCNO>NCT01217645</DOCNO>
	<brief_summary>This study assess distribution , metabolism excretion [ 14C ] AZD6765 single-dose intravenous administration .</brief_summary>
	<brief_title>Study Assess Distribution , Metabolism Excretion 14CAZD6765 After Single-Dose Intravenous Administration</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>Subjects must normal creatinine clearance â‰¥60 mL/min Subjects selfidentify race Asian History clinically significant medical , neurologic psychiatric disease judge investigator History symptomatic orthostatic hypotension ( ie , postural syncope ) Subjects receive radiolabelled study drug within 12 month Screening Visit . Subjects monitor radioactivity part occupation Subjects expose radiation level background , ( eg , throughXRay examination ) &gt; 5mSv last year , &gt; 10 mSv last 5 year cumulative total &gt; 1mSv per year life .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Major depression disorder</keyword>
</DOC>